Home›Screener›RVMD›Profile
F
35/100

Revolution Medicines

RVMDPrecision Oncology
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Revolution Medicines (RVMD) is the lead sponsor of 12 active clinical trials listed on ClinicalTrials.gov[4], including 4 Phase 3[1], 5 Phase 2[2], 8 Phase 1[3].

Trial NCT07252232[5] evaluates daraxonrasib in Pancreatic Cancer with a target enrollment of 500 participants. Trial NCT07491445[6] evaluates daraxonrasib in Pancreatic Cancer with a target enrollment of 900 participants. Trial NCT06881784[7] evaluates daraxonrasib in NSCLC (Non-small Cell Lung Cancer) with a target enrollment of 420 participants.

RVMD has 8 Form 4 insider filings recorded at the SEC in the past 30 days[8].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. ClinicalTrials.gov (2026-04-11) ↗
  5. ClinicalTrials.gov · NCT07252232 (2026-04-06) ↗
  6. ClinicalTrials.gov · NCT07491445 (2026-04-06) ↗
  7. ClinicalTrials.gov · NCT06881784 (2026-03-12) ↗
  8. SEC EDGAR · 0001628171 (2026-04-11) ↗
🔬
Clinical Trials
12
NCT05379985Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06040541Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer, RAS G12D-mutated NSCLC
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06445062Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC, Gastrointestinal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06625320Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma), NSCLC (Advanced Non-small Cell Lung Cancer)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07252232Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC), Resected Pancreatic Adenocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07349537Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), PDAC, CRC, NSCLC, Pancreatic Cancer, Lung Cancer (NSCLC), Advanced Solid Tumors
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07397338Advanced Solid Tumors, Metastatic Solid Tumors, Non-small Cell Lung Cancer (NSCLC), NSCLC, Colorectal Cancer (CRC), CRC
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
8 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Precision Oncology)
IDYAIDEAYA Biosciences
D
RLAYRelay Therapeutics
D
ELVNEnliven Therapeutics
D
Data Provenance
cik1 verified
clinical trial12 verified
insider buy1 verified
trial count4 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR